Pharma & Biotech

Protara Therapeutics, a clinical-stage biotechnology firm, delivered an impressive quarterly performance that has reignited market interest. The company not only...

The medical technology firm TransMedics continues to post impressive operational results, yet its share price tells a conflicting story. Despite...

The biotechnology sector has a standout performer demonstrating how strategic achievements and impressive quarterly results can propel equity values to...

The pharmaceutical giant from Indianapolis is experiencing an exceptional period in the markets, propelled by a powerful combination of analyst...

Pacific Biosciences shares are demonstrating significant momentum in today's trading session, propelled by a landmark regulatory achievement in China that...

While Ocugen's latest financial results showed continued losses, market participants are focusing squarely on the company's advancing clinical programs. The...

Cassava Sciences finds itself navigating turbulent market conditions as its equity value continues to deteriorate. Despite a fleeting rebound on...

In a strategic move to bolster its leadership team, Redcare Pharmacy has announced the appointment of a seasoned e-commerce executive...

In a surprising turn of events, Danish pharmaceutical leader Novo Nordisk has strategically withdrawn from the high-stakes bidding competition for...

While Bluejay Diagnostics continues to make tangible progress in the clinical development of its sepsis diagnostic technology, its shares are...